Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYHA1815 in Advanced Solid Tumors
NCT05105464Phase 2Unknown
- Sponsor
- Shanghai Runshi Pharmaceutical Technology Co., Ltd.
- Start
- Jun 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SYHA1815 in solid tumor, thyroid cancer, non-small cell lung cancer (NSCLC), gastric cancer (GC), colorectal cancer (CRC), sponsored by Shanghai Runshi Pharmaceutical Technology Co., Ltd.. Status: unknown.
02
Drugs
SYHA1815
03
Conditions
solid tumorthyroid cancernon-small cell lung cancer (NSCLC)gastric cancer (GC)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05105464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05105464.